1 to 9 of 18 results

Takeda files for diabetes drug trelagliptin succinate approval in Japan

Takeda files for diabetes drug trelagliptin succinate approval in Japan


Takeda Pharmaceutical, Japan’s largest drugmaker, has submitted a New Drug Application to the Japanese…

Asia-PacificBlopressCardio-vascularDiabetesJapanPharmaceuticalRegulationResearchTakeda Pharmaceuticalstrelagliptin

Actavis challenges Multaq and Colcrys patents


Ireland-headquartered generic drugmaker Actavis revealed on Friday (February 28) that French pharma giant…

ActavisAnti-Arthritics/RheumaticsCardio-vascularColcrysGenericsLegalMultaqNorth AmericaPatents & Trade marksRegulationSanofiTakeda PharmaceuticalsUSA

Takeda out-licenses Edarbi and Edarbyclor


Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) has entered into a license, development and…

Arbor PharmaceuticalsCardio-vascularEdarbiEdarbyclorLicensingNorth AmericaPharmaceuticalTakeda Pharmaceuticals

Further highlights from European Society of Cardiology meeting


The ongoing European Society of Cardiology meeting in Amsterdam, Netherlands, continues to produce both…

ActelionalogliptinAmgenBiotechnologyCardio-vascularCytokineticsDiabetesomecamtiv mecarbilOpsumitPharmaceuticalResearchRespiratory and PulmonaryTakeda Pharmaceuticals

Japan briefs: Takeda files for Azilva comb; Sandoz seeks filgrastim biosimilar approval


Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says that it submitted a New Drug Application…

Amlodipine BesylateAsia-PacificAzilvaBiotechnologyCardio-vascularEP2006FilgrastimGenericsImmunologicalsNovartisPharmaceuticalRegulationSandozTakeda PharmaceuticalsZarzio

Japan launches for Lotriga and Argamate


Norway's Pronova BioPharma (OSE: PRON.OL), recently the subject of a $845 million takeover bid from Germany's…

ArgamateAstellas PharmaCardio-vascularLotrigaMarkets & MarketingNephrology and HepatologyNorth AmericaPharmaceuticalPronova BioPharmaSanwa KagakuTakeda Pharmaceuticals

EU Ombudsman wants more transparency concerning medicines for children


European Union Ombudsman Nikiforos Diamandouros has called on the European Medicines Agency to increase…

AstraZenecaCandesartan CilexetilCardio-vascularEuropePharmaceuticalRegulationResearchTakeda Pharmaceuticals

Takeda and Pronova highlight TAK-085 Japanese Ph III trial results


Japanese drug major Takeda Pharmaceutical (TYO: 4502) and Norway-based lipid therapies specialist Pronova…

Cardio-vascularPharmaceuticalPronova BioPharmaResearchTakeda Pharmaceuticals

1 to 9 of 18 results

Back to top